Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Transplantation

  Free Subscription


Articles published in Transpl Int

Retrieve available abstracts of 85 articles:
HTML format
Text format



Single Articles


    March 2017
  1. SGARABOTTO D, Fasolato S, Vianello F, Vittadello F, et al
    Antibiotic prophylaxis for preventing post orthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid?
    Transpl Int. 2017 Mar 23. doi: 10.1111/tri.12955.
    PubMed     Text format     Abstract available


  2. HARRIES L, Schrem H, Stahmeyer JT, Krauth C, et al
    High Resource Utilization in Liver Transplantation - How Strongly differ Costs between the Care Sectors and What are the Main Cost Drivers?
    Transpl Int. 2017 Mar 11. doi: 10.1111/tri.12950.
    PubMed     Text format     Abstract available


  3. ROLLER J, Glanemann M
    Keep the pressure! Correlation of hemodynamic instability after reperfusion and severity of acute kidney injury following liver transplantation.
    Transpl Int. 2017 Mar 7. doi: 10.1111/tri.12948.
    PubMed     Text format     Abstract available


    February 2017
  4. SCHNITZBAUER AA, Bechstein WO
    Equitable distribution in rare indications for liver transplantation: the dilemma of the too small tablecloth continues!
    Transpl Int. 2017 Feb 22. doi: 10.1111/tri.12942.
    PubMed     Text format     Abstract available


  5. GROSSI PA
    Liver Transplantation from donors with positive blood cultures: increased risk of graft failure or opportunity to expand the donor pool?
    Transpl Int. 2017 Feb 20. doi: 10.1111/tri.12939.
    PubMed     Text format     Abstract available


    January 2017
  6. BURRA P, Zanetto A
    Filling the gap between clinical trials and real life in the treatment of severe HCV recurrence after liver transplantation.
    Transpl Int. 2017 Jan 19. doi: 10.1111/tri.12917.
    PubMed     Text format     Abstract available


  7. DE BOER JD, Koopman JJ, Metselaar HJ, Braat AE, et al
    Liver transplantation with geriatric liver allografts: the current situation in Eurotransplant.
    Transpl Int. 2017 Jan 6. doi: 10.1111/tri.12914.
    PubMed     Text format     Abstract available


    December 2016
  8. HERZER K, Welzel TM, Spengler U, Hinrichsen H, et al
    Real-World Experience With Daclatasvir Plus Sofosbuvir +/- Ribavirin for Post-Liver Transplant HCV Recurrence and Severe Liver Disease.
    Transpl Int. 2016 Dec 24. doi: 10.1111/tri.12910.
    PubMed     Text format     Abstract available


    November 2016
  9. DE MARTIN E, Antonini TM, Coilly A, Pittau G, et al
    HCV and HEV recurrence after liver transplantation: one antiviral therapy for two viruses.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12898.
    PubMed     Text format     Abstract available


  10. O'LEARY JG, Fontana RJ, Brown K, Burton JR Jr, et al
    Efficacy and Safety of Simeprevir and Sofosbuvir With and Without Ribavirin in Subjects With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant: The Randomized GALAXY Study.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12896.
    PubMed     Text format     Abstract available


  11. HUAMAN MA, Vilchez V, Mei X, Shah MB, et al
    Decreased Graft Survival in Liver Transplant Recipients of Donors with Positive Blood Cultures: A review of the UNOS dataset.
    Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12900.
    PubMed     Text format     Abstract available


  12. KALISVAART M, de Haan JE, Hesselink DA, Polak WG, et al
    The Postreperfusion Syndrome Is Associated With Acute Kidney Injury Following Donation After Brain Death Liver Transplantation.
    Transpl Int. 2016 Nov 19. doi: 10.1111/tri.12891.
    PubMed     Text format     Abstract available


    October 2016
  13. VOUTILAINEN SH, Kosola SK, Tervahartiala TI, Sorsa TA, et al
    Liver and serum expression of matrix metalloproteinases in asymptomatic pediatric liver transplant recipients.
    Transpl Int. 2016 Oct 23. doi: 10.1111/tri.12879.
    PubMed     Text format     Abstract available


  14. SINGAL AK, Fang X, Kaif M, Hasanin M, et al
    Primary Biliary Cirrhosis Has High Wait List Mortality Among Patients Listed For Liver Transplantation.
    Transpl Int. 2016 Oct 18. doi: 10.1111/tri.12877.
    PubMed     Text format     Abstract available


  15. STINE JG, Argo CK, Pelletier SJ, Maluf DG, et al
    Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis.
    Transpl Int. 2016 Oct 6. doi: 10.1111/tri.12855.
    PubMed     Text format     Abstract available


    September 2016
  16. NEVIERE R, Trinh-Duc P, Hulo S, Edme JL, et al
    Predictive value of exhaled nitric oxide and aerobic capacity for sepsis complications after liver transplantion.
    Transpl Int. 2016 Sep 20. doi: 10.1111/tri.12861.
    PubMed     Text format     Abstract available


    August 2016
  17. ROBERTSON FP, Magill LJ, Wright GP, Fuller B, et al
    A systematic review and meta-analysis of donor ischaemic preconditioning in liver transplantation.
    Transpl Int. 2016 Aug 26. doi: 10.1111/tri.12849.
    PubMed     Text format     Abstract available


    July 2016
  18. PAMECHA V, Mahansaria SS, Kumar S, Bharathy KG, et al
    Association of thrombocytopenia with outcome following adult living donor liver transplantation.
    Transpl Int. 2016 Jul 18. doi: 10.1111/tri.12819.
    PubMed     Text format     Abstract available


  19. PITCHAIMUTHU M, Roll GR, Zia Z, Olliff S, et al
    Long-term follow-up after endovascular treatment of hepatic venous outflow obstruction following liver transplantation.
    Transpl Int. 2016 Jul 2. doi: 10.1111/tri.12817.
    PubMed     Text format     Abstract available


    May 2016
  20. TESTINO G
    Alcohol and liver transplantation: the six-month abstinence rule is not a dogma.
    Transpl Int. 2016 May 9. doi: 10.1111/tri.12790.
    PubMed     Text format     Abstract available


    April 2016
  21. LEE KW, Lee S, Dong Kyu O, Na BG, et al
    Outcome of Partial Reconstruction of Multiple Hepatic Arteries in Pediatric Living Donor Liver Transplantation Using Left Liver Grafts.
    Transpl Int. 2016 Apr 26. doi: 10.1111/tri.12787.
    PubMed     Text format     Abstract available


  22. BRANDL A, Stolzlechner P, Eschertzhuber S, Aigner F, et al
    Inferior graft survival of hepatitis B core positive grafts is not influenced by post-transplant hepatitis B infection in liver recipients--5-year single-center experience.
    Transpl Int. 2016;29:471-82.
    PubMed     Text format     Abstract available


    March 2016
  23. TIAN Y, Lesurtel M, Ungethuem U, Song Z, et al
    A novel technique in mouse liver transplantation (with video).
    Transpl Int. 2016 Mar 31. doi: 10.1111/tri.12780.
    PubMed     Text format     Abstract available


  24. IJTSMA AJ, van der Hilst CS, Nijkamp DM, Bottema JT, et al
    Does The MELD System Provide Equal Access to Liver Transplantation for Patients with Different ABO Blood Groups?
    Transpl Int. 2016 Mar 14. doi: 10.1111/tri.12774.
    PubMed     Text format     Abstract available


    February 2016
  25. KOLLMANN D, Rasoul-Rockenschaub S, Steiner I, Freundorfer E, et al
    Good outcome after liver transplantation for ALD without a 6-months abstinence rule prior to transplantation including post-transplant CDT-monitoring for alcohol relapse assessment - a retrospective study.
    Transpl Int. 2016 Feb 10. doi: 10.1111/tri.12756.
    PubMed     Text format     Abstract available


  26. ELDEEN FZ, Mourad MM, Bhandari M, Roll G, et al
    Accepting multiple simultaneous liver offers does not negatively impact transplant outcomes.
    Transpl Int. 2016;29:227-33.
    PubMed     Text format     Abstract available


    January 2016
  27. KIVELA JM, Kosola S, Perasaari J, Makisalo H, et al
    Donor-specific antibodies after pediatric liver transplantation: a cross-sectional study of 50 patients.
    Transpl Int. 2016 Jan 25. doi: 10.1111/tri.12747.
    PubMed     Text format     Abstract available


  28. ZHONG Z, Ye S, Xiong Y, Wu L, et al
    Decreased expression of mitochondrial aldehyde dehydrogenase-2 induces liver injury via activation of the mitogen-activated protein kinase pathway.
    Transpl Int. 2016;29:98-107.
    PubMed     Text format     Abstract available


  29. PANDANABOYANA S, Longbotham D, Hostert L, Attia M, et al
    Transplantation of liver and kidney from donors with malignancy at the time of donation: an experience from a single centre.
    Transpl Int. 2016;29:73-80.
    PubMed     Text format     Abstract available


    December 2015
  30. RODRIGUEZ-PERALVAREZ M, Rico-Juri JM, Tsochatzis E, Burra P, et al
    Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.
    Transpl Int. 2015 Dec 29. doi: 10.1111/tri.12737.
    PubMed     Text format     Abstract available


  31. RUSSO FP, Zanetto A, Burra P
    Timing for treatment of HCV recurrence after liver transplantation: the earlier the better.
    Transpl Int. 2015 Dec 29. doi: 10.1111/tri.12739.
    PubMed     Text format     Abstract available


  32. LIESE J, Peveling-Oberhag J, Doering C, Schnitzbauer AA, et al
    A possible role of miRNAs as predictive markers for the recurrence of hepatocellular carcinoma after liver transplantation.
    Transpl Int. 2015 Dec 23. doi: 10.1111/tri.12733.
    PubMed     Text format     Abstract available


  33. GAMBATO M, Crespo G, Torres F, LLovet L, et al
    Simple prediction of long-term clinical outcomes in patients with mild hepatitis c recurrence after liver transplantation.
    Transpl Int. 2015 Dec 11. doi: 10.1111/tri.12730.
    PubMed     Text format     Abstract available


    November 2015
  34. ROBERTSON FP, Bessell PR, Diaz-Nieto R, Thomas N, et al
    High serum Aspartate Transaminase (AST) levels on day 3 post liver transplantation correlates with graft and patient survival and would be a valid surrogate for outcome in liver transplantation clinical trials.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12723.
    PubMed     Text format     Abstract available


  35. LIBRIZZI S, Guadalix S, Martinez-Diaz Guerra G, Allo G, et al
    Trabecular bone sc0re in patients with liver transplants after one year of risedronate treatment.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12725.
    PubMed     Text format     Abstract available


    October 2015
  36. DARWISH MURAD S, Metselaar HJ
    The invasion of fatty liver disease in liver transplantation.
    Transpl Int. 2015 Oct 24. doi: 10.1111/tri.12707.
    PubMed     Text format     Abstract available


    September 2015
  37. ALKHOURI N, Hanouneh IA, Zein NN, Lopez R, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis (NASH) in Young Patients.
    Transpl Int. 2015 Sep 24. doi: 10.1111/tri.12694.
    PubMed     Text format     Abstract available


    August 2015
  38. ARRIZZA C, De Gottardi A, Foglia E, Baumgartner M, et al
    Reversal of cardiomyopathy in propionic acidemia after liver transplantation: a 10-year follow-up.
    Transpl Int. 2015 Aug 27. doi: 10.1111/tri.12677.
    PubMed     Text format     Abstract available


  39. BELLO AD, Congy-Jolivet N, Danjoux M, Muscari F, et al
    De novo Donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients.
    Transpl Int. 2015 Aug 25. doi: 10.1111/tri.12654.
    PubMed     Text format     Abstract available


  40. O'LEARY JG
    Donor-specific alloantibodies in liver transplantation: How should we define and improve long-term success?
    Transpl Int. 2015 Aug 18. doi: 10.1111/tri.12661.
    PubMed     Text format     Abstract available


  41. UEDA Y, Uemoto S
    Decreased tacrolimus concentration following a temporal increase during interferon-free therapy with asunaprevir and daclatasvir in patients with recurrent hepatitis C after liver transplantation.
    Transpl Int. 2015 Aug 13. doi: 10.1111/tri.12653.
    PubMed     Text format     Abstract available


    July 2015
  42. BURRA P, De Martin E, Zanetto A, Senzolo M, et al
    "HCV and liver transplantation: where do we stand?"
    Transpl Int. 2015 Jul 21. doi: 10.1111/tri.12642.
    PubMed     Text format     Abstract available


  43. BHAT M, Hathcock M, Kremers WK, Darwish Murad S, et al
    Portal Vein Encasement Predicts Neoadjuvant Therapy Response in Liver Transplantation for Perihilar Cholangiocarcinoma protocol.
    Transpl Int. 2015 Jul 16. doi: 10.1111/tri.12640.
    PubMed     Text format     Abstract available


  44. SPETZLER VN, Goldaracena N, Kaths JM, Marquez M, et al
    High Pre-operative Bilirubin Values Protect Against Reperfusion Injury after Live Donor Liver Transplantation.
    Transpl Int. 2015 Jul 6. doi: 10.1111/tri.12634.
    PubMed     Text format     Abstract available


  45. LEVESQUE E, Paugam-Burtz C, Saliba F, Khoy-Ear L, et al
    Fungal complications after Candida preservation fluid contamination in liver-transplant recipients.
    Transpl Int. 2015 Jul 6. doi: 10.1111/tri.12633.
    PubMed     Text format     Abstract available


  46. HOUBEN P, Manzini G, Kremer M, Arend J, et al
    Graft rinse prior to reperfusion in liver transplantation: Literature review and online survey within the Eurotransplant community.
    Transpl Int. 2015 Jul 6. doi: 10.1111/tri.12631.
    PubMed     Text format     Abstract available


  47. THOMAS MN, Nadalin S, Schemmer P, Pascher A, et al
    A German survey of the abdominal transplantation surgical work force.
    Transpl Int. 2015;28:849-56.
    PubMed     Text format     Abstract available


  48. HALDAR D, Chen F, Byron J, Elsharkawy AM, et al
    Is it time to revisit contraindications to organ donation from donors with a JAK-2 mutation? Safe use of a liver allograft from a donor with essential thrombocythaemia.
    Transpl Int. 2015;28:881-3.
    PubMed     Text format     Abstract available


    June 2015
  49. BONACCI M, Londono MC, Esforzado N, Forns X, et al
    Antiviral Treatment with Sofosbuvir and Simeprevir in a Kidney-Transplant Recipient with HCV-Decompensated Cirrhosis: Viral Eradication and Removal from the Liver Transplant Waiting List.
    Transpl Int. 2015 Jun 13. doi: 10.1111/tri.12622.
    PubMed     Text format     Abstract available


  50. UCHIDA H, Fukuda A, Sasaki K, Miyasaka M, et al
    Donor Double Common Bile Duct in Living Donor Liver Transplantation.
    Transpl Int. 2015 Jun 5. doi: 10.1111/tri.12619.
    PubMed     Text format     Abstract available


    May 2015
  51. BHATTI AB, Dar FS, Zia H
    Where Angels Fear to Tread: Donor Bile Duct Division in Living Donor Liver Transplant.
    Transpl Int. 2015 May 27. doi: 10.1111/tri.12613.
    PubMed     Text format     Abstract available


  52. KURAMITSU K, Fukumoto T, Yano Y, Hirano H, et al
    A case of intravascular lymphoma diagnosed in an explanted liver after liver transplantation.
    Transpl Int. 2015 May 23. doi: 10.1111/tri.12611.
    PubMed     Text format     Abstract available


    April 2015
  53. VITALE A, Spolverato G, Burra P, De Feo TM, et al
    Cost-effectiveness of Pre-Transplant Sofosbuvir for Preventing Recurrent HCV Infection after Liver Transplantation.
    Transpl Int. 2015 Apr 11. doi: 10.1111/tri.12591.
    PubMed     Text format     Abstract available


  54. DETRY O
    Should abo-incompatible deceased liver transplantation be reconsidered?
    Transpl Int. 2015 Apr 3. doi: 10.1111/tri.12573.
    PubMed     Text format     Abstract available


    March 2015
  55. FORTUNE BE, Martinez-Camacho A, Kreidler S, Gralla J, et al
    Post-Transplant Survival is Improved for Hepatitis C Recipients who are RNA Negative at Time of Liver Transplantation.
    Transpl Int. 2015 Mar 26. doi: 10.1111/tri.12568.
    PubMed     Text format     Abstract available


  56. ROMPIANESI G, Montalti R, Cautero N, Ruvo N, et al
    Neurological complications after liver transplantation as a consequence of immunosuppression: univariate and multivariate analysis of risk factors.
    Transpl Int. 2015 Mar 19. doi: 10.1111/tri.12564.
    PubMed     Text format     Abstract available


  57. SUH KS, Suh SW, Lee JM, Choi Y, et al
    Living donor liver transplantation using a left liver extended to right anterior sector.
    Transpl Int. 2015 Mar 16. doi: 10.1111/tri.12559.
    PubMed     Text format     Abstract available


  58. PISELLI P, Burra P, Lauro A, Baccarani U, et al
    Head and neck and esophageal cancers after liver transplant: results from a multicenter cohort study. Italy, 1997-2010.
    Transpl Int. 2015 Mar 16. doi: 10.1111/tri.12555.
    PubMed     Text format     Abstract available


  59. THORSEN T, Dahlgren US, Aandahl EM, Grzyb K, et al
    Liver transplantation with deceased ABO-incompatible donors is life-saving but associated with increased risk of rejection and post-transplant complications.
    Transpl Int. 2015 Mar 3. doi: 10.1111/tri.12552.
    PubMed     Text format     Abstract available


  60. WESTERKAMP AC, de Boer MT, van den Berg AP, Gouw AS, et al
    Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
    Transpl Int. 2015;28:319-29.
    PubMed     Text format     Abstract available


    February 2015
  61. LEE S, Kim JM, Choi GS, Kwon CH, et al
    Sustained linear growth and preserved renal function in 10-year survivors of pediatric liver transplantation.
    Transpl Int. 2015 Feb 24. doi: 10.1111/tri.12550.
    PubMed     Text format     Abstract available


  62. CAREDDU L, Zanfi C, Pantaleo A, Loforte A, et al
    Combined Heart-Liver transplantation: a single center experience.
    Transpl Int. 2015 Feb 24. doi: 10.1111/tri.12549.
    PubMed     Text format     Abstract available


  63. BINET I
    Liver transplant and kidney disease: the scope of the problem.
    Transpl Int. 2015 Feb 24. doi: 10.1111/tri.12547.
    PubMed     Text format     Abstract available


  64. WATT KD
    Is 40 the new 30?
    Transpl Int. 2015;28:146-7.
    PubMed     Text format    


  65. TRIPON S, Francoz C, Albuquerque A, Paradis V, et al
    Interactions between virus-related factors and post-transplant ascites in patients with hepatitis C and no cirrhosis: role of cryoglobulinemia.
    Transpl Int. 2015;28:162-9.
    PubMed     Text format     Abstract available


    January 2015
  66. ZHOU J, Ju W, Yuan X, Jiao X, et al
    ABO-incompatible liver transplantation for severe hepatitis B patients.
    Transpl Int. 2015 Jan 29. doi: 10.1111/tri.12531.
    PubMed     Text format     Abstract available


  67. TANG B, Wang Z, Qi G, Yuan S, et al
    MicroRNA-155 Deficiency Attenuates Ischemia Reperfusion Injury after Liver Transplantation in Mice.
    Transpl Int. 2015 Jan 22. doi: 10.1111/tri.12528.
    PubMed     Text format     Abstract available


  68. DEN DULK AC, Korkmaz KS, de Rooij BJ, Sutton ME, et al
    High peak alanine aminotransferase determines extra risk for nonanastomotic biliary strictures after liver transplantation with donation after circulatory death.
    Transpl Int. 2015 Jan 19. doi: 10.1111/tri.12524.
    PubMed     Text format     Abstract available


  69. WEISMULLER TJ, Lerch C, Evangelidou E, Strassburg CP, et al
    A pocket guide to identify patients at risk for chronic kidney disease after liver transplantation.
    Transpl Int. 2015 Jan 9. doi: 10.1111/tri.12522.
    PubMed     Text format     Abstract available


  70. RODRIGUEZ-PERALVAREZ M, Garcia-Caparros C, Tsochatzis E, Germani G, et al
    Lack of agreement for defining "clinical suspicion of rejection" in liver transplantation: a model to select candidates for liver biopsy.
    Transpl Int. 2015 Jan 3. doi: 10.1111/tri.12514.
    PubMed     Text format     Abstract available


  71. PANDANABOYANA S, Bell R, Bartlett AJ, McCall J, et al
    Meta-analysis of Duct to duct versus Roux en Y biliary reconstruction following Liver Transplantation for Primary Sclerosing Cholangitis (PSC).
    Transpl Int. 2015 Jan 3. doi: 10.1111/tri.12513.
    PubMed     Text format     Abstract available


  72. TOBIASCH M, Anetsberger A, Blobner M, Thorban S, et al
    Donor-organ distribution according to urgency of need or outcome maximization in liver transplantation. A questionnaire survey among patients and medical staff.
    Transpl Int. 2015 Jan 3. doi: 10.1111/tri.12512.
    PubMed     Text format     Abstract available


    December 2014
  73. CHOLONGITAS E, Burra P
    Reply to Andrea Mancuso and Giovanni Perricone "Time to resize the role of everolimus as treatment of hepatocellular carcinoma recurrence after liver transplant."
    Transpl Int. 2014 Dec 1. doi: 10.1111/tri.12496.
    PubMed     Text format     Abstract available


    November 2014
  74. LIU Y, Wang J, Yang P, Lu H, et al
    Delayed rearterialization unlikely leads to non-anastomotic stricture but causes temporary injury on bile duct after liver transplantation.
    Transpl Int. 2014 Nov 19. doi: 10.1111/tri.12490.
    PubMed     Text format     Abstract available


  75. DIRCHWOLF M, Ruf AE, Biggins SW, Bisigniano L, et al
    Donor selection criteria for liver transplantation in Argentina: are current standards too rigorous?
    Transpl Int. 2014 Nov 19. doi: 10.1111/tri.12489.
    PubMed     Text format     Abstract available


  76. SINGHAL A, Wilson GC, Wima K, Quillin RC, et al
    Impact of Recipient Morbid Obesity on Outcomes After Liver Transplantation.
    Transpl Int. 2014 Nov 1. doi: 10.1111/tri.12483.
    PubMed     Text format     Abstract available


  77. THYS K, Schwering KL, Siebelink M, Dobbels F, et al
    Psychosocial impact of pediatric living-donor kidney and liver transplantation on recipients, donors and the family: a systematic review.
    Transpl Int. 2014 Nov 1. doi: 10.1111/tri.12481.
    PubMed     Text format     Abstract available


    August 2014
  78. INDOLFI G, Berczes R, Pelliccioli I, Bosisio M, et al
    Neonatal haemochromatosis with reversible pituitary involvement.
    Transpl Int. 2014;27:e76-9.
    PubMed     Text format     Abstract available


    July 2014
  79. MARGREITER R
    Response to: Jan Lerut, Laudatio for Prof. Raimund Margreiter on the occasion of the honorary membership of ESOT.
    Transpl Int. 2014;27:e68.
    PubMed     Text format    


  80. LAMBRECHT JR, Skauby M, Trondsen E, Vaktskjold A, et al
    Laparoscopic repair of incisional hernia in solid organ-transplanted patients: the method of choice?
    Transpl Int. 2014;27:712-20.
    PubMed     Text format     Abstract available


  81. DE GEEST S, Burkhalter H, Bogert L, Berben L, et al
    Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Coho
    Transpl Int. 2014;27:657-66.
    PubMed     Text format     Abstract available


    June 2014
  82. MOURAD MM, Reay M, Muiesan P, Mirza DF, et al
    Patient with liver dysfunction while maintained on veno-venous extracorporeal membrane oxygenation should not be overlooked as a potential donor.
    Transpl Int. 2014;27:e50-3.
    PubMed     Text format     Abstract available


  83. DOEDE T, Brocker V, Fruhauf NR
    Organ donation after Lethal Methanol Intoxication.
    Transpl Int. 2014;27:e48-9.
    PubMed     Text format    


    May 2014
  84. ALMEIDA-PAULO GN, Lubomirov R, Alonso-Sanchez NL, Espinosa-Roman L, et al
    Limited Sampling Strategies For Tacrolimus Exposure (Auc ) Prediction After Prograf And Advagraf Administration In Children And Adolescents With Liver Or Kidney Transplants.
    Transpl Int. 2014 May 27. doi: 10.1111/tri.12362.
    PubMed     Text format     Abstract available


    March 2014
  85. HIBI T, Nishida S, Sageshima J, Levi DM, et al
    Excessive immunosuppression as a potential cause of poor survival in simultaneous liver-kidney transplantation for hepatitis C.
    Transpl Int. 2014 Mar 7. doi: 10.1111/tri.12303.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: